| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 12, 2025 | BLFS Biolife Solutions Inc | Aebersold Sarah60 | Chief Human Resources Officer | Sell | 53 | $26.54 | $1,406.62 | - | -12.3% | -18.1% | |
| Feb 12, 2025 | STIM Neuronetics, Inc. | MacAn William Andrew66 | EVP, GC, CCO And Cs | Sell | 12,175 | $3.83 | $46,630.25 | -3.0% | +11.8% | -60.3% | |
| Feb 12, 2025 | BLFS Biolife Solutions Inc | Mathew Aby J.68 | EVP &Chief Scientific Officer | Sell | 92 | $26.54 | $2,441.68 | - | -12.3% | -18.1% | |
| Feb 12, 2025 | STIM Neuronetics, Inc. | Furlong Stephen74 | EVP, CFO And Treasurer | Sell | 10,845 | $3.83 | $41,536.35 | -2.2% | +11.8% | -60.3% | |
| Feb 12, 2025 | BSX Boston Scientific Corp | Mirviss Jeffrey B.45 | EVP&Pres, Periph Intervent | Sell | 13,022 | $105.06 | $1,368,073.09 | -31.4% | -2.7% | -29.9% | |
| Feb 12, 2025 | BSX Boston Scientific Corp | Brennan Daniel J.47 | EVP And CFO | Sell | 15,087 | $105.07 | $1,585,135.27 | -5.9% | -2.7% | -29.9% | |
| Feb 12, 2025 | BSX Boston Scientific Corp | Sorenson John Bradley55 | EVP, Global Operations | Sell | 6,389 | $105.06 | $671,249.42 | -20.8% | -2.7% | -29.9% | |
| Feb 11, 2025 | BSX Boston Scientific Corp | Ludwig Edward J60 | Director | Sell | 12,000 | $105.48 | $1,265,815.20 | -33.0% | -2.9% | -30.7% | |
| Feb 11, 2025 | SERA Sera Prognostics, Inc. | Harrison Robert Gardner74 | Chief Information Officer | Sell | 554 | $3.97 | $2,199.38 | -0.5% | -42.4% | -35.7% | |
| Feb 11, 2025 | CNMD Conmed Corp | Glaze Richard | Chief Information Officer | Sell | 257 | $65.35 | $16,796.03 | -100% | -6.7% | -34.9% | |
| Feb 11, 2025 | ISRG Intuitive Surgical Inc | Curet Myriam56 | EVP &Chief Medical Officer | Sell | 408 | $589.75 | $240,618.00 | -53.6% | -5.1% | -16.1% | |
| Feb 11, 2025 | INSP Inspire Medical Systems, Inc. | Rondoni John79 | Chief Technology Officer | Sell | 583 | $170.49 | $99,395.67 | -5.3% | -15.0% | -62.9% | |
| Feb 10, 2025 | NXGL Nexgel, Inc. | Henry Scott Robert72 | Director | Sell | 3,000 | $3.27 | $9,798.30 | -2.1% | -16.3% | -59.4% | |
| Feb 10, 2025 | STIM Neuronetics, Inc. | MacAn William Andrew66 | EVP, GC, CCO And Cs | Sell | 1,970 | $3.28 | $6,461.60 | -0.5% | +7.3% | -62.2% | |
| Feb 10, 2025 | BDX Becton Dickinson & Co | Henderson Jeffrey William65 | Director | Buy | 1,500 | $233.62 | $350,430.00 | +23.0% | -23.3% | -2.8% | |
| Feb 10, 2025 | STIM Neuronetics, Inc. | Furlong Stephen74 | EVP, CFO And Treasurer | Sell | 14,836 | $3.28 | $48,662.08 | -3.0% | +7.3% | -62.2% | |
| Feb 10, 2025 | RMD Resmed Inc | Sandercock Brett62 | Chief Financial Officer | Sell | 1,000 | $238.98 | $238,980.00 | -1.1% | +3.8% | +10.5% | |
| Feb 10, 2025 | STIM Neuronetics, Inc. | Sullivan Keith J61 | President And CEO | Sell | 40,992 | $3.28 | $134,453.76 | -3.1% | +7.3% | -62.2% | |
| Feb 10, 2025 | ISRG Intuitive Surgical Inc | Samath Jamie62 | EVP &CFO &Enterprise Technol | Sell | 269 | $590.00 | $158,710.00 | -3.9% | -5.8% | -16.9% | |
| Feb 10, 2025 | SRTS Sensus Healthcare, Inc. | Sardano Michael73 | President And General Counsel | Buy | 1,000 | $5.95 | $5,950.00 | +0.9% | -25.0% | -19.1% | |
| Feb 10, 2025 | SRTS Sensus Healthcare, Inc. | Rampolla Javier | Chief Financial Officer | Buy | 501 | $5.95 | $2,980.95 | +1.2% | -25.0% | -19.1% | |
| Feb 10, 2025 | IDXX Idexx Laboratories Inc /de | Fennell George | Executive Vice President | Sell | 9,986 | $462.53 | $4,618,861.53 | -55.0% | +9.6% | +39.1% | |
| Feb 7, 2025 | IDXX Idexx Laboratories Inc /de | Szostak M Anne | Director | Sell | 3,000 | $465.95 | $1,397,835.00 | -49.5% | +6.6% | +40.2% | |
| Feb 7, 2025 | BSX Boston Scientific Corp | Sorenson John Bradley55 | EVP, Global Operations | Sell | 6,528 | $104.97 | $685,244.16 | -19.8% | -1.9% | -27.5% | |
| Feb 7, 2025 | RMD Resmed Inc | Farrell Michael J.63 | Chief Executive Officer | Sell | 8,009 | $236.77 | $1,896,306.95 | -1.7% | +2.6% | +14.6% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.